A Russell Tupling Selected Research

sarcolipin

1/2019	Phospholamban deficiency does not alter skeletal muscle SERCA pumping efficiency or predispose mice to diet-induced obesity.
5/2017	Sarcolipin expression is not required for the mitochondrial enzymatic response to physical activity or diet.
1/2017	Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice.
1/2016	Sarcolipin knockout mice fed a high-fat diet exhibit altered indices of adipose tissue inflammation and remodeling.
12/2015	Sarcoplasmic Reticulum Phospholipid Fatty Acid Composition and Sarcolipin Content in Rat Skeletal Muscle.
9/2015	Persistence of diet-induced obesity despite access to voluntary activity in mice lacking sarcolipin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Russell Tupling Research Topics

Disease

7	Obesity 01/2019 - 06/2015
2	Insulin Resistance 01/2022 - 10/2017
2	Hypoxia (Hypoxemia) 01/2022 - 12/2019
2	Fatigue 11/2019 - 06/2004
2	Glucose Intolerance 01/2019 - 05/2017
2	Muscular Dystrophies (Muscular Dystrophy) 03/2018 - 01/2017
2	Atrophy 08/2017 - 01/2017
2	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2017 - 08/2015
2	Muscular Atrophy (Muscle Atrophy) 01/2017 - 01/2016
2	AIDS-Related Complex (ARC) 03/2015 - 03/2010
1	Type 2 Diabetes Mellitus (MODY) 12/2019
1	Hypertrophy 08/2017
1	Inflammation (Inflammations) 01/2016
1	Hyperphagia (Overeating) 12/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2015
1	Parkinson Disease (Parkinson's Disease) 06/2015
1	Myalgia 11/2014
1	Weight Gain 09/2013
1	Heart Failure 09/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2011
1	Central Core Myopathy (Central Core Disease) 12/2009
1	Muscular Diseases (Myopathy) 12/2009

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 08/2017 - 03/2010
6	sarcolipinIBA 01/2019 - 09/2015
3	phospholambanIBA 01/2019 - 08/2015
3	Adenosine Triphosphatases (ATPase)IBA 05/2017 - 06/2004
3	CalciumIBA 03/2015 - 06/2004
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
2	CalcineurinIBA 11/2019 - 08/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 12/2015
2	EnzymesIBA 12/2015 - 01/2011
2	Phosphates (Orthophosphate)IBA 11/2014 - 01/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	DioxygenasesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 12/2019
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 11/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2019
1	Liposomes (Liposome)IBA 03/2018
1	phosphatidylethanolamineIBA 03/2018
1	Phosphatidylcholines (Phosphatidylcholine)IBA 03/2018
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2017
1	LipidsIBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	CatecholaminesIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 12/2015
1	Hormones (Hormone)IBA 12/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015
1	CaspasesIBA 03/2015
1	Apoptosis Inducing FactorIBA 03/2015
1	CalpainIBA 03/2015
1	Apoptosis Regulatory ProteinsIBA 03/2015
1	Propranolol (Inderal)FDA LinkGeneric 09/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2011
1	Glucose-6-PhosphateIBA 01/2011
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2011
1	glucose-1-phosphateIBA 01/2011
1	Pyruvic Acid (Pyruvate)IBA 01/2011
1	FructoseIBA 01/2011
1	GlycogenIBA 01/2011
1	PhosphofructokinasesIBA 01/2011
1	Peptide Hydrolases (Proteases)FDA Link 03/2010
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2009

Therapy/Procedure

1	Ovariectomy (Oophorectomy) 12/2015